SEHK:968
SEHK:968Semiconductor

Asian Market Insights: Zhejiang Taimei Medical Technology Among 3 Compelling Penny Stocks

The Asian markets have been closely watched as global economic dynamics shift, with the recent U.S.-China trade truce providing a temporary boost to investor sentiment. In this context, penny stocks, though often overlooked, can present intriguing opportunities when they exhibit robust financial health. These smaller or newer companies hold potential for growth and value that larger firms might not offer, and we will explore three such compelling stocks in the Asian market.
SEHK:2338
SEHK:2338Machinery

Top Asian Dividend Stocks To Watch In November 2025

As global markets navigate a complex landscape of interest rate adjustments and trade negotiations, Asian markets are also experiencing notable developments. With Japan's stock markets reaching record highs and China focusing on domestic demand to bolster growth, investors are increasingly interested in dividend stocks as a potential source of steady income amidst these shifting economic conditions. A good dividend stock often combines reliable payouts with the ability to adapt to evolving...
SEHK:3692
SEHK:3692Pharmaceuticals

Does Regulatory Progress for RET Inhibitor Reshape the Oncology Pipeline Momentum at Hansoh (SEHK:3692)?

The board of directors of Hansoh Pharmaceutical Group announced that China's National Medical Products Administration has accepted the New Drug Application for HS-10365 capsules, a selective RET inhibitor for treating adult patients with RET fusion-positive locally advanced or metastatic non-small cell lung cancer. This regulatory milestone not only reflects progress in Hansoh’s oncology pipeline, but also highlights the company’s potential to address significant unmet needs in lung cancer...
SEHK:1286
SEHK:1286Machinery

A Look at Impro Precision Industries (SEHK:1286) Valuation Following Strong Q3 Revenue Growth and Momentum

Impro Precision Industries (SEHK:1286) just posted a strong year-on-year jump in third quarter revenue, with standout gains in its diversified industrials and AI-related segments. The company’s positive sales outlook continues to draw attention from investors. See our latest analysis for Impro Precision Industries. Momentum has clearly shifted in Impro Precision Industries’ favor, with the share price climbing 12.87% over the past month and surging 65% in the last quarter. That is part of a...
SEHK:1093
SEHK:1093Pharmaceuticals

Did CSPC’s siRNA and ADC Regulatory Wins Just Shift Its (SEHK:1093) Investment Narrative?

In recent announcements by CSPC Pharmaceutical Group, the company received approval to begin clinical trials for its innovative siRNA drug SYH2061 targeting complement component C5, and its co-developed HER2-targeting antibody-drug conjugate JSKN003 was granted Breakthrough Therapy Designation in China for advanced colorectal cancer. These regulatory milestones highlight CSPC’s expanding capabilities in developing first-in-class treatments addressing significant unmet clinical needs within...
SEHK:9973
SEHK:9973Auto

Chery Automobile (SEHK:9973): Evaluating Valuation as Shares Trade in a Tight Range

Chery Automobile (SEHK:9973) has been trading in a relatively narrow range, with its share price closing at HK$32.38. Over the past month, the stock edged up by 1%, reflecting investors’ cautious optimism. See our latest analysis for Chery Automobile. Momentum has been fairly muted for Chery Automobile, as this year’s modest 1.4% share price return suggests investors are still waiting to see if recent progress translates into stronger growth. After a flurry of updates earlier in the year, the...
SEHK:2696
SEHK:2696Biotechs

A Look at Shanghai Henlius Biotech’s (SEHK:2696) Valuation Following Its Strategic Immunotherapy Partnership

Shanghai Henlius Biotech (SEHK:2696) has entered a strategic partnership with Forlong Biotechnology to jointly develop next-generation cancer immunotherapies. This move brings together Henlius’s antibody expertise and Forlong’s engineered cytokine technologies, further expanding Henlius’s oncology pipeline. See our latest analysis for Shanghai Henlius Biotech. Shanghai Henlius Biotech’s latest partnership news comes at a time when its stock has seen remarkable momentum, with the 1-year total...
SEHK:2331
SEHK:2331Luxury

Li Ning (SEHK:2331): Assessing Valuation After Q3 2025 Earnings Call Spurs Investor Focus

Li Ning (SEHK:2331) just held its Q3 2025 earnings call, drawing focused attention from investors and analysts. These quarterly updates provide a revealing look at the company’s financial health and management’s outlook for the months ahead. See our latest analysis for Li Ning. Li Ning’s Q3 earnings call appears to have been a catalyst for movement, with the share price rising 1.75% on the day but pulling back 7.05% over the past week. While short-term volatility remains, the company’s total...
SEHK:992
SEHK:992Tech

Is Lenovo a Bargain After AI Expansion Drives 16% Rally in 2025?

Ever wondered if Lenovo Group is truly a bargain, or if the market is missing something big? You are in the right place to dig into what is really driving value for this tech giant. Lenovo Group’s stock has been anything but flat, with a 16.0% year-to-date climb and an impressive 162.2% gain over the last five years, though it dipped -1.4% this week as the market recalibrated expectations. Global headlines have swirled around Lenovo's expansion in AI-powered devices and fresh investment in...